L22 Pill - yellow round
Pill with imprint L22 is Yellow, Round and has been identified as Solifenacin Succinate 5 mg. It is supplied by Macleods Pharmaceuticals Limited.
Solifenacin is used in the treatment of Overactive Bladder; Urinary Incontinence; Urinary Frequency; Neurogenic Bladder; Neurogenic Detrusor Overactivity and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Solifenacin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for L22
Solifenacin Succinate
- Imprint
- L22
- Strength
- 5 mg
- Color
- Yellow (light yellow)
- Shape
- Round (biconvex, film coated)
- Availability
- Prescription only
- Drug Class
- Urinary antispasmodics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Macleods Pharmaceuticals Limited
- National Drug Code (NDC)
- 33342-0148
Related images for "L22"
More about solifenacin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (198)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: urinary antispasmodics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
